Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel

Gynecologic Oncology Reports

Volumn 5, Issue , 2013, Pages 70-71

  de Leon, Maria C B ^a   Bolla, Sridhar ^b   Greene, Barbra ^a   Hutchinson, Lauren ^a   Del Priore, Giuseppe ^a  

^a INDIANA UNIVERSITY   (United States)

^b American Health Network Hematology Oncology   (United States)

Author keywords

Abraxane; Docetaxel; Hypersensitivity reaction; Nab paclitaxel; Paclitaxel; Taxol

Indexed keywords

ADRENALIN; CARBOPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; DOCETAXEL; DOXORUBICIN; FAMOTIDINE; METHYLPREDNISOLONE SODIUM SUCCINATE; PACLITAXEL;

ABDOMINAL PAIN; ADULT; ARTICLE; BLOATING; CANCER CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; FEMALE; HUMAN; HYPOXIA; MALIGNANT ASCITES; MULTIPLE CYCLE TREATMENT; OMENTECTOMY; OVARY CARCINOMA; PELVIS TUMOR; PRIORITY JOURNAL; RESPIRATORY DISTRESS; URTICARIA;

EID: 84879306090     PISSN: None     EISSN: 2211338X     Source Type: Journal    
DOI: 10.1016/j.gynor.2013.05.003     Document Type: Article

References (5)

1. Coleman R.L., Brady W.E., McMeekin S., Rose P.G., Soper J.T., et al. A phase II evaluation of nanoparticle, albumin-bound nab-paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: a Gynecologic Oncology Group study. Gynecol. Oncol. 2011, 122:111-115.
2. Del Priore G., Smith P., Warshal D.P., Dubeshter B., Angel C. Paclitaxel associated hypersensitivity reaction despite high-dose steroids and prolonged infusions. Gynecol. Oncol. 1995, 11:2456-2458.
3. Dizon D.S., Schwartz J., Rojan A., Miller J., et al. Cross-sensitivity between paclitaxel and docetaxel in women's cancers programs. Gynecol. Oncol. 2006, 100:149-151.
4. Essayan D.M., Kagey-Sobatka A., Colarusso P.J., Lichtenstein L.M., et al. Successful parenteral desensitization to paclitaxel. J. Allergy Clin. Immunol. 1996, 97:42-46.
5. Fader A.N., Rose P.G. Abraxane for the treatment of gynecologic cancer patients with severe hypersensitivity reactions to paclitaxel. Int. J. Gynecol. Cancer 2009, 19:1281-1283.